(76) proposed that cell surface IgM acts as an “initiator oncogene” for B cell lymphomas, with the IgM-BCR potently promoting B cell proliferation and IgG-BCRs preferentially promoting B-cell differentiation programs. This evidence concerns the gene BCR and B-cell non-Hodgkin lymphoma.